Application

15334235 · COMBINATION THERAPIES FOR B-CELL LYMPHOMAS COMPRISING ADMINISTRATION OF ANTI-CD20 ANTIBODY

Filed 2016-10-25 · Abandoned The official file ↗ · Art unit 1644 · Examiner Ronald B Schwadron Hard · CPC A61K 39/395 · Biogen Inc. · Arnold & Porter Kaye Scholer LLP

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

0.7 mo

to disposition 10.8 mo

Statutes raised

102 103 112 DP

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.